Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.

Molecular cell | 2019

BRCA1 functions at two distinct steps during homologous recombination (HR). Initially, it promotes DNA end resection, and subsequently it recruits the PALB2 and BRCA2 mediator complex, which stabilizes RAD51-DNA nucleoprotein filaments. Loss of 53BP1 rescues the HR defect in BRCA1-deficient cells by increasing resection, suggesting that BRCA1's downstream role in RAD51 loading is dispensable when 53BP1 is absent. Here we show that the E3 ubiquitin ligase RNF168, in addition to its canonical role in inhibiting end resection, acts in a redundant manner with BRCA1 to load PALB2 onto damaged DNA. Loss of RNF168 negates the synthetic rescue of BRCA1 deficiency by 53BP1 deletion, and it predisposes BRCA1 heterozygous mice to cancer. BRCA1+/-RNF168-/- cells lack RAD51 foci and are hypersensitive to PARP inhibitor, whereas forced targeting of PALB2 to DNA breaks in mutant cells circumvents BRCA1 haploinsufficiency. Inhibiting the chromatin ubiquitin pathway may, therefore, be a synthetic lethality strategy for BRCA1-deficient cancers.

Pubmed ID: 30704900 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GraphPad Prism (tool)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

Phospho RPA32 (S4/S8) Antibody (antibody)

RRID:AB_210547

This unknown targets Phospho-RPA32 (Ser4, Ser8)

View all literature mentions

NEW Anti-RNF168 (antibody)

RRID:AB_11205761

This polyclonal targets NEW RNF168

View all literature mentions

Rad51 (H-92) (antibody)

RRID:AB_2253533

This polyclonal targets RAD51

View all literature mentions

PALB2 Antibody (antibody)

RRID:AB_890608

This unknown targets PALB2

View all literature mentions

RPA32 (4E4) Rat mAb (antibody)

RRID:AB_2238543

This monoclonal targets RPA32

View all literature mentions

gamma H2AX Antibody (antibody)

RRID:AB_10002815

This unknown targets gamma H2AX

View all literature mentions

Anti-GFP (antibody)

RRID:AB_390913

This monoclonal targets GFP

View all literature mentions

HA-Tag (6E2) Mouse mAb (antibody)

RRID:AB_10691311

This monoclonal targets HA-Tag

View all literature mentions

CENPF antibody (antibody)

RRID:AB_304721

This polyclonal targets CENPF

View all literature mentions

BrdU (antibody)

RRID:AB_400326

This monoclonal targets BrdU

View all literature mentions

BRCC36 Antibody (antibody)

RRID:AB_1966097

This unknown targets BRCC36

View all literature mentions

Anti-p53 Binding Protein 1 (Ab-1) Rabbit pAb (antibody)

RRID:AB_564982

This polyclonal targets p53 Binding Protein 1 (Ab-1) Rabbit pAb

View all literature mentions

53BP1 Antibody (antibody)

RRID:AB_10001695

This polyclonal targets 53BP1

View all literature mentions

BRCA2 Antibody (antibody)

RRID:AB_10952240

This unknown targets BRCA2

View all literature mentions

BOSC-23 (cell line)

RRID:CVCL_4401

Cell line BOSC-23 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions